Author

Shalaka Agarkhedkar

Observed name: Shalaka S Agarkhedkar

Institution: Dr. D. Y. Patil Medical College, Hospital and Research Centre

Observed institutions: Pfizer (United States), Dr. D. Y. Patil Medical College, Hospital and Research Centre

OpenAlex ID: A5083348820

Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen)

2015 · BJ Mahendra, DH Ashwath Narayana, et al. · Human Vaccines & Immunotherapeutics · 21

Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine

2014 · Prasad S Kulkarni, Sharad Agarkhedkar, et al. · Human Vaccines & Immunotherapeutics · 19

Safety and immunogenicity of an investigational meningococcal ACWY conjugate vaccine (MenACWY-CRM) in healthy Indian subjects aged 2 to 75 years

2015 · Sanjay Lalwani, Sharad Agarkhedkar, et al. · International Journal of Infectious Diseases · 17

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants

2016 · Sanjay K. Lalwani, Sharad Agarkhedkar, et al. · Human Vaccines & Immunotherapeutics · 12

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children 6–17 Years of Age in India

2017 · Sharad Agarkhedkar, Christine Juergens, et al. · The Pediatric Infectious Disease Journal · 4

Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial

2018 · Rajesh Joshi, Neeta Hanumante, et al. · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 1

Works count: 6

Citation count: 74

H-index: 4

I10-index: 4